Saydam, G. Et Al. 2018. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up. Hematology , vol.23, no.10 , 771-777.

Saydam, G., Haznedaroglu, I. C., Kaynar, L., Yavuz, A. S., Ali, R., Guvenc, B., ... Akay, O. M.(2018). Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up. Hematology , vol.23, no.10, 771-777.

Saydam, Guray Et Al. "Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up," Hematology , vol.23, no.10, 771-777, 2018

Saydam, Guray Et Al. "Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up." Hematology , vol.23, no.10, pp.771-777, 2018

Saydam, G. Et Al. (2018) . "Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up." Hematology , vol.23, no.10, pp.771-777.

@article{article, author={Guray Saydam Et Al. }, title={Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up}, journal={Hematology}, year=2018, pages={771-777} }